• Email:
  • Password:
  • Remember Me
 
Lecture Hall Diabetic Foot | Analysis

The Diabetic Charcot Foot: the Clinicians Enigma


Available Credits
CME 0.75
CPME 0.75

Robert Frykberg
Robert Frykberg, DPM, MPH
Carl T. Hayden VA MedicalCenter, Phoenix, AZ
System Requirements Method of Participation Disclosure Information

Dr. Frykberg will give an in-depth overview of diabetic Charcot foot. He will review the history of Charcot foot, incidence, presentation, diagnosis and treatment options available.

Goal and Objective
After participating in this activity, the viewer should be better able to:
1. Identify diseases that will lead to Charcot foot
2. Describe the morbidity and mortality of Charcot compared to other diabetic diseases
3. Describe the pathogenesis of Charcot
4. List predisposing factors for Charcot
5. Describe the role of proinflammatory cytokines on Charcot

Estimated time to complete this activity is 43 minutes.

Physicians, diabetes educators, and other health care professionals who treat patients with diabetes.
Accreditation and Designation of Credit
MEDICINE: Accreditation Statement: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Mount Sinai School of Medicine and Present eLearning Systems LLC. The Mount Sinai School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement: The Mount Sinai School of Medicine designates this Enduring material activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Release Date: 06/15/2011 Expiration Date: 06/15/2012
Peer Review: on 02/17/2011

PODIATRY: The Ohio College of Podiatric Medicine(OCPM) is an approved sponsor of Continuing Podiatric Medical Education through the Council on Podiatric Medical Education (CPME).

The Ohio College of Podiatric Medicine credits this activity for 0.75 credit hour.

Release Date: 02/17/2011 Expiration Date: 12/30/2012
Peer Review: on 02/17/2011

System Requirements
The Diabetic Charcot Foot: the Clinicians Enigma
Top
A Pentium-III class computer with a minimum of 256MB of system RAM is required to view Online Internet lectures. While a 56Kbps dial-up connection is supported, a Cable or DSL broadband Internet is strongly recommended for optimal video playback. You will need an up-to-date web browser such as Internet Explorer, Mozilla Firefox, or the AOL browser with Java and JavaScript enabled. Some lectures require the use of Internet Explorer to run and will not run with other browsers. Lectures may require the use of helper applications or plug-ins to access the materials. For example, most online lectures/presentations require either Adobe Flash Player or Windows Media Player (both free). To be able to print completion certificates Adobe Acrobat Reader must be installed.
Method of Participation
The Diabetic Charcot Foot: the Clinicians Enigma
Top
Complete the 4 steps to earn CE/CME credit:
  • Complete and submit the required pre-test
  • View Lecture
  • Complete and submit post-test and program evaluation. Credit will be issued with a passing score of 70% or better.
  • Click Print Certificate.
Disclosure Information
The Diabetic Charcot Foot: the Clinicians Enigma
Top
It is the policy of PRESENT e-Learning Systems and it's accreditors to insure balance, independence, objectivity and scientific rigor in all its individually sponsored or jointly sponsored educational programs. All faculty participating in any PRESENT e-Learning Systems sponsored programs are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts.
Robert Frykberg, DPM, MPH has disclosed that he receives Honorarium/Expenses and serves on the Speaker's Bureaus for KCI, Merck, Pfizer and Organogenesis. He receives Grant/Research Support from Oculus Innovative Sciences.